jueves, 24 de noviembre de 2011

IVIG and Rituximab Regimen to Reduce Anti-HLA Antibodies In Renal Transplantation

This video blog by Ron Shapiro, MD discusses new clinical trial data on emerging therapeutic options for highly-sensitized renal transplant candidates awaiting

Read more about allergy and ...

No hay comentarios:

Publicar un comentario